CytomX Therapeutics Correlations

CTMX Stock

USD 0.67 0.07 11.67%

The current 90-days correlation between CytomX Therapeutics and Spero Therapeutics is 0.27 (i.e., Modest diversification). The correlation of CytomX Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

CytomX Therapeutics Correlation With Market

Very weak diversification

The correlation between CytomX Therapeutics and DJI is 0.4 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding CytomX Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CytomX Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For more information on how to buy CytomX Stock please use our How to Invest in CytomX Therapeutics guide.

Moving together with CytomX Stock

0.82	CDIOW	Cardio Diagnostics	Pair Corr
0.87	ELVN	Enliven Therapeutics	Pair Corr
0.83	SCLX	Scilex Holding	Pair Corr
0.87	ASMB	Assembly Biosciences Earnings Call This Week	Pair Corr
0.87	CDIO	Cardio Diagnostics	Pair Corr
0.61	CMND	Clearmind Medicine Common	Pair Corr
0.93	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.61	DIS	Walt Disney	Pair Corr
0.83	MSFT	Microsoft	Pair Corr

Moving against CytomX Stock

0.82	WM	Waste Management	Pair Corr
0.8	LUCD	Lucid Diagnostics	Pair Corr
0.76	GE	GE Aerospace	Pair Corr
0.63	PLX	Protalix Biotherapeutics	Pair Corr
0.4	PG	Procter Gamble	Pair Corr
0.88	JNJ	Johnson Johnson	Pair Corr
0.82	T	ATT Inc Earnings Call Tomorrow	Pair Corr
0.81	MMM	3M Company	Pair Corr
0.76	CVX	Chevron Corp	Pair Corr
0.66	IBM	International Business	Pair Corr
0.64	CSCO	Cisco Systems	Pair Corr
0.61	XOM	Exxon Mobil Corp	Pair Corr
0.51	INTC	Intel	Pair Corr

Related Correlations Analysis

	SPRO	NLTX	TIL	NXTC	ASMB	ACHL	NUVB
SPRO		0.0	0.18	0.74	0.87	-0.39	0.54	SPRO
NLTX	0.0		0.0	0.0	0.0	0.0	0.0	NLTX
TIL	0.18	0.0		0.28	0.31	-0.26	0.24	TIL
NXTC	0.74	0.0	0.28		0.75	-0.28	0.36	NXTC
ASMB	0.87	0.0	0.31	0.75		-0.62	0.72	ASMB
ACHL	-0.39	0.0	-0.26	-0.28	-0.62		-0.74	ACHL
NUVB	0.54	0.0	0.24	0.36	0.72	-0.74		NUVB
	SPRO	NLTX	TIL	NXTC	ASMB	ACHL	NUVB

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ASMB	+ 0.87	SPRO
ASMB	+ 0.75	NXTC
NXTC	+ 0.74	SPRO
NUVB	+ 0.72	ASMB
NUVB	+ 0.54	SPRO
NUVB	+ 0.36	NXTC

High negative correlations

NUVB	- 0.74	ACHL
ACHL	- 0.62	ASMB
ACHL	- 0.39	SPRO
ACHL	- 0.28	NXTC
ACHL	- 0.26	TIL
NUVB	- 0.0	NLTX

Risk-Adjusted Indicators

There is a big difference between CytomX Stock performing well and CytomX Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze CytomX Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
SPRO	2.59	(0.31)	0.00	(0.73)	0.00	0.00	5.13	(6.25)	21.98
NLTX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
TIL	5.56	0.11	0.00	(0.03)	0.00	0.00	13.25	(9.64)	34.30
NXTC	3.52	(0.75)	0.00	(0.48)	0.00	0.00	6.49	(7.25)	21.57
ASMB	3.04	(0.35)	0.00	(0.37)	0.00	0.00	6.63	(5.05)	24.82
ACHL	1.69	0.74	0.58	38.28	0.31	(3.04)	3.47	(1.72)	22.77
NUVB	3.28	(0.53)	0.00	0.41	0.00	0.00	6.88	(7.38)	28.03

CytomX Therapeutics Corporate Management

JD Rowland	General VP	Profile
MBA BS	Head VP	Profile
Danielle OlanderMoghadassian	Senior Officer	Profile
YuWaye MD	Senior Officer	Profile
Christopher Ogden	Principal Accounting	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC